T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 79 filers reported holding T2 BIOSYSTEMS INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -57.9% | 50,000 | 0.0% | 0.00% | -75.0% |
| Q1 2022 | $19,000 | -26.9% | 50,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $26,000 | -44.7% | 50,000 | -2.9% | 0.01% | -53.8% |
| Q3 2021 | $47,000 | -23.0% | 51,500 | 0.0% | 0.01% | -31.6% |
| Q2 2021 | $61,000 | -7.6% | 51,500 | +1.6% | 0.02% | -29.6% |
| Q1 2021 | $66,000 | +6.5% | 50,675 | +1.4% | 0.03% | -3.6% |
| Q4 2020 | $62,000 | -6.1% | 50,000 | 0.0% | 0.03% | -22.2% |
| Q3 2020 | $66,000 | -13.2% | 50,000 | 0.0% | 0.04% | -25.0% |
| Q2 2020 | $76,000 | +216.7% | 50,000 | +25.0% | 0.05% | +200.0% |
| Q1 2020 | $24,000 | +100.0% | 40,000 | +300.0% | 0.02% | +128.6% |
| Q4 2019 | $12,000 | -50.0% | 10,000 | 0.0% | 0.01% | -56.2% |
| Q3 2019 | $24,000 | +41.2% | 10,000 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $17,000 | -34.6% | 10,000 | 0.0% | 0.01% | -36.8% |
| Q1 2019 | $26,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
| Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
| Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
| ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
| TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
| THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
| PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
| Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
| Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |